Physician profile
Rachel E Hasler
NPI 1205368164
$4,941.24
in general payments reported to CMS, 2019-2025
15 companies · $801 in 2025
The $801 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $220 · 2021: $1,578 · 2022: $507 · 2023: $810 · 2024: $201 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,836.41 | 2019-2025 | Precision 1, Precision7, Rhopressa |
| Coopervision INC. | $1,244.90 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $356.63 | 2019-2021 | |
| Glaukos Corporation | $287.70 | 2021-2025 | Istent Infinite |
| Johnson & Johnson Vision Care, INC. | $235.67 | 2020-2025 | Acuvue |
| Novartis Pharmaceuticals Corporation | $181.86 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $173.00 | 2023-2025 | Infuse, Miebo, Xiidra |
| Rxsight INC | $148.75 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Kala Pharmaceuticals, INC. | $143.10 | 2021 | |
| Sun Pharmaceutical Industries INC. | $133.26 | 2020-2021 | |
| Oyster Point Pharma, INC. | $72.48 | 2022-2025 | Ryzumvi, Tyrvaya |
| Biotissue Holdings INC. | $43.05 | 2019-2022 | |
| Allergan, INC. | $37.21 | 2022 | |
| Shire North American Group INC | $24.51 | 2019 | |
| Abbvie INC. | $22.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Hasler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.